Celebrating each success: proportion of remission as a measure of recovery from polysubstance use disorder proportion of remission; a recovery measure. [PDF]
Quddos F +4 more
europepmc +1 more source
A real-world pharmacovigilance study of four anti-non-small cell lung cancer drugs using the WHO-VigiAccess database. [PDF]
Fang C +8 more
europepmc +1 more source
Medical Complications After Mechanical Thrombectomy: Analysis of Trends in US Admissions From 2010 to 2022. [PDF]
Levin-Carrion Y +14 more
europepmc +1 more source
Long-term safety evaluation of mirtazapine: A real-world pharmacovigilance study based on the FAERS database. [PDF]
Zhao K, Liu J.
europepmc +1 more source
Disproportionality Analysis of Hematologic Adverse Event Signals Associated with Venetoclax in Combination with Senescence-Inducing Chemotherapy. [PDF]
Saleh T +3 more
europepmc +1 more source
The Innate and Adaptive Immune Functions of Osteoblast-Lineage Cells. [PDF]
Hossain MA, Hurtado PR, Atkins GJ.
europepmc +1 more source
Psychiatric Adverse Events and Administration Challenges Associated with GLP-1 Receptor Agonists for Weight Loss: A Real-World Analysis. [PDF]
Hindi A, Mekkawy M, Shokr H.
europepmc +1 more source
Alternative splicing: an underexplored layer in immune receptor regulation, systemic resistance and priming. [PDF]
Aballay FE +6 more
europepmc +1 more source
Current Understanding of Cell-Surface Immune Receptors for MAMPs and Plant Parasites in the Solanaceae Family. [PDF]
Leuschen-Kohl R, Iyer-Pascuzzi AS.
europepmc +1 more source

